Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
Author:
creacionmx
Recombination Theories Refuted by Positive Epistasis
Is Tenofovir + Emtricitabine Superior to Zidovudine + Lamivudine?
Three-Year Final Results of the NEFA Simplification Trial
The PD-1/PDL-1 Pathway: Another Magic Bullet for HIV Therapy?
Nevirapine or Efavirenz for Replacing. Protease Inhibitors?
Hopes for New Cyclophilin Inhibitors of Hepatitis C Virus in HIV Coinfected Patients
WHO Releases New HIV Guidelines Aimed At Resource-Limited Settings
Frequent âNaturalâ? Zoonotic Transmission of Simian foamy Virus to Humans
When to Start Antiretroviral Therapy in HIV Patients with Tuberculosis
Vectored Immunoprophylaxis – An Innovative Approach to Prevent HIV Infection
←
previous
Next
→